These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 29627656)
1. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives. Bakr RB; Azouz AA; Abdellatif KR J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Oct; 80():164-173. PubMed ID: 29929077 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds. Atatreh N; Youssef AM; Ghattas MA; Al Sorkhy M; Alrawashdeh S; Al-Harbi KB; El-Ashmawy IM; Almundarij TI; Abdelghani AA; Abd-El-Aziz AS Bioorg Chem; 2019 May; 86():393-400. PubMed ID: 30763886 [TBL] [Abstract][Full Text] [Related]
5. COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core. Abdelall EKA; Lamie PF; Ahmed AKM; El-Nahass ES Bioorg Chem; 2019 May; 86():235-253. PubMed ID: 30716621 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles. Faidallah HM; Rostom SAF Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives. Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties. Somakala K; Tariq S; Amir M Bioorg Chem; 2019 Jun; 87():550-559. PubMed ID: 30928877 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and anti-inflammatory assessment of certain substituted 1,2,4-triazoles bearing tetrahydroisoquinoline scaffold as COX 1/2-inhibitors. Abo-Elmagd MI; Hassan RM; Aboutabl ME; Amin KM; El-Azzouny AA; Aboul-Enein MN Bioorg Chem; 2024 Sep; 150():107577. PubMed ID: 38941697 [TBL] [Abstract][Full Text] [Related]
16. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations. Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152 [TBL] [Abstract][Full Text] [Related]